z-logo
Premium
Interleukin‐4 inhibits lipopolysaccharide‐induced expression of prostaglandin H synthase‐2 in human alveolar macrophages
Author(s) -
Yano Tatsutoshi,
Hopkins Harvey A.,
Hemplel Stephen L.,
Monick Martha,
Hunninghake Gary W.
Publication year - 1995
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1041650110
Subject(s) - lipopolysaccharide , chemistry , prostaglandin e2 , alveolar macrophage , atp synthase , microbiology and biotechnology , immunology , macrophage , biology , biochemistry , endocrinology , enzyme , in vitro
Several studies have shown that interleukin‐4 (IL‐4) down‐regulates synthesis of prostaglandin E 2 (PGE 2 ). We evaluated the mechanisms for this suppression in human alveolar macrophages (HAMs). Normal HAMs were obtained from healthy nonsmoking volunteers. The cells either remained unstimulated, or were exposed to 10 μg/ml of lipopolysaccharide (LPS) and/or various amounts of IL‐4. LPS alone induced the synthesis of large amounts of PGE 2 and prostaglandin H synthase‐2 (PGHS‐2) protein. This effect of LPS was suppressed by increasing amounts of IL‐4. Expression of LPS‐induced PGHS‐2 mRNA was also inhibited by IL‐4. In addition, IL‐4 inhibited expression of CD14, which is a receptor for LPS bound to the LPS‐binding protein (LBP). We conclude that IL‐4 down‐regulates LPS‐induced release of PGE 2 , by reducing expression of the enzyme, PGHS‐2. One potential mechanism for this effect of IL‐4 is a reduced expression of CD14, which is the LPS‐LBP receptor. © 1995 Wiley‐Liss Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom